Posted on

ARA-290 Benefits

ARA-290 Benefits
ARA-290 Benefits

The research peptide ARA-290 benefits essential neuropathic pain in trials, by improving cholesterol and promoting wound repair. The peptide works on the nervous system and can regrow some nerve types. Ultimately the main reason for its effectiveness in neuropathic pain. However, ARA-290 is showing it has many more strings to its bow and can treat various health issues.

<<BUY ARA-290 16mg Here Now for Research Only>>

Benefits from ARA 290 Clinical Trials

For researchers, ARA-290 is an exciting find and shows promising results in boosting insulin sensitivity, heart disease, nerve pain and more. It can effectively be a future treatment for

-Neurodegenerative disorders including Parkinson’s and Alzheimer’s
– Spinal cord injuries
– Strokes
– Sarcoidosis
– Insulin sensitivity
– Diabetic retinopathy
– Nerve pain
– brain injuries

What is ARA-290?

ARA 290 is an artificial peptide derived from the natural hormone Erythropoietin (EPO), which encourages the production of red cells. EPO is made in the kidneys, brain, bone marrow, liver, lung and spleen and can reduce inflammatory pathways.

For sufferers of neuropathy, you will already know this. But, for those new to this, when something in the body stops working, there is an instant inflammatory reaction, like pain, heat, loss of function, redness and swelling; thus, you want rid of this. So, paracrine signals and innate repair receptors work similarly to a phone sending signals to communicate. The innate repair receptors catch the offending hormones and ultimately action anti-inflammatory and tissue repair pathways, reducing pain and healing tissue. Neuropathy is common and can affect up to 30% of Americans of all ages.

Some factors that can increase the chance of people being affected by neuropathy are diabetes, high blood pressure, high cholesterol, obesity, and drinking large amounts of alcohol. Certain professions with repetitive movement are also at risk.

Is ARA-290 Dosage a Neuropathy Treatment?

Neuropathy is where there is damage or defection to one or several nerves and causes pain, tingling, numbness, and muscle weakness to the affected body area. It often begins in the hands and feet but can occur anywhere in the body. Neuropathy is also known as peripheral neuropathy. It reveals a problem in the peripheral nervous system, a group of nerves outside the spinal cord and brain. At the same time, the spinal cord and brain are the central nervous system.

The two systems work together, signaling the network of nerves or the peripheral nervous system with information to the central station of the brain and spinal cord. Neuropathy occurs when the nerve cells are destroyed or damaged, disrupting communication with the brain. It can affect one or more nerves in an area, causing painful symptoms.

ARA 290 Nerve Regeneration

Ariam Pharmaceuticals are the brains behind the research hormone ARA290. In studies is effective in treating metabolic control and neuropathy, especially in type 2 diabetes patients. The present global situation with type 2 diabetes is a significant concern for health services. The disease is distinguished by hyperglycemia and lipid-induced inflammatory processes, which harm tissues. Currently, primary diabetes therapy consists of controlling glucose as a treatment for diabetic complications. For example, in neuropathy (or nerve damage), this treatment aims to get reasonable metabolic control to relieve symptoms. So far, this therapeutic approach to diabetes attempts to control the causes of glucose intolerance and influence repair systems to stop or reverse organ damage.

ARA 290 Peptide Side Effects

As with all research chemicals, ARA290 is still an experimental peptide. So, ARA 290 has not yet met the complete safety profile by the FDA. It still needs more testing and trials for side effects and toxicity. But, clinical trials are continually showing positive results with ARA-290 on patients with neuropathic pain with sarcoidosis. Sarcoidosis is an inflammatory disease which can affect various organs. It is a rare disease and causes abnormal masses of inflamed tissue to form on some body organs. Sarcoidosis occurs when the immune system reacts to foreign bodies such as bacteria, chemicals and viruses.

Studies to date have found ARA-290 to be relatively safe and uncommon. However, some side effects from trials included:
-High blood pressure
-Fast heart rate
-Liver enzyme elevation

Summary of ARA-290 Benefits

ARA-290 is an exciting new research peptide in the laboratories at the moment. While we know it is particularly effective in treating neuropathy it is also helping:

  • Improve blood vessel health
  • Reducing Inflammation
  • Protecting tissue
  • Improving immune system
  • Controlling pain

Scientist are also logging positive results with ARA-290 on celiac disease, multiple Sclerosis, HIV and inflammatory bowel disease. While it could be a while until ARA-290 is treating any of the above conditions it certainly seems to be showing excellent results.



Posted on

ARA-290 For Sale at Great Prices!

ARA-290 for salePeptide Science ARA-290 for sale – here now for the excellent price of $95.00! If you want to save more money then see our buy-in bulk offers below. We supply a range of great offers for example:

<<Buy 5 for $90.00 each, or save even more money and buy 10 for $85.00 each>>

Take advantage of even more savings when you buy with us such as; free shipping if you live in the USA when you spend over $200.00! But, don’t be disappointed if you live outside of the USA, we ship to most countries for the flat rate of $15.00. Plus when your spend over $300 you get 1 FREE Bacteriostatic Water


If you are in the research and development community and want to buy ARA290 peptides for research, we are the best choice. USA Peptides supplies over 100 research amino acids, proteins, and peptides manufactured by leading US-based research company Peptide Sciences. All of the research products are tested for purity so are safe and free of additives. If you work in this sector of education and scientific research you are guaranteed the best quality research chemicals here!

What is ARA-290 Dosage Achieving in Research?

ARA-290 is a peptide presently being researched for treating neuropathic pain in patients with sarcoidosis. Tests are underway to treat the disease and find a long-term cure for this condition.

The peptide ARA-290 can promote blood vessel growth and cell survival, change blood pressure, and produce neuroprotective effects in diabetic neuropathy.

ARA 290 provides neuroprotective and pain relief effects with no stimulation to red blood cell production. ARA-290 is an exciting research peptide that shows impressive results in studies in controlling neuropathic pain. In addition, further investigations show ARA-290 is a potential wound repair treatment for chronic diabetes and the condition Lupus.

ARA 290 Neuropathy Pain Reliefs

ARA-290 is currently being tested for its safety as a treatment for neuropathic pain for sarcoidosis patients. The pain mostly affects nerve fibers and Sarcoidosis is a chronic systemic granulomatous disease affecting young to older individuals. The condition is progressive and can lead to significant organ impairment, nerve fiber loss, disabling neuropathic symptoms, and pain being the main complaint. These symptoms cause a considerable loss of quality of life and often the inability to work. While mortality is not common, it can increase over time.

ARA 290 is a peptide that has shown the potential to relieve neuropathic pain associated with conditions such as sarcoidosis. It modulates the innate repair receptor (IRR), which helps regulate inflammatory responses and tissue repair. ARA 290 can reduce pain and improve the quality of life in individuals with neuropathy. While further research is needed to establish its efficacy and safety, initial studies suggest that ARA 290 may hold promise as a therapeutic option for neuropathic pain management.


Cibinetide (ARA 290)

ARA 290 is also known as Cabinetide, and is classed as a research substance that comes under the class of drugs including:

  • Analgesics
  • Anti-inflammatory
  • Antidepressants
  • Antihyperglycemic
  • Antirheumatics
  • Cardiovascular therapies
  • Eye disorder therapies
  • Hepatoprotectants
  • Peptides
  • Radioprotectives
  • Mechanism of Action is Erythropoietin receptor agonists
  • Status in research is to treat Sarcoidosis, Neuropathic pain, and Transplant rejection.

A Guide to Cibinetide

Cibinetide is a synthetic peptide derived from the amino acid sequence of the endogenous peptide AcSDKP (N-acetyl-seryl-aspartyl-lysyl-proline). In studies, it has the potential to treat inflammatory and autoimmune conditions.

Cibinetide is known for its ability to modulate the innate repair receptor (IRR) and promote tissue repair processes. It has shown anti-inflammatory effects, the ability to reduce oxidative stress, and the potential to promote neuroprotection and tissue regeneration. Studies show Cibinetide effectively treats conditions such as sarcoidosis, diabetic neuropathy, and other inflammatory disorders.

What is the Benefit of ARA290 Peptide?

ARA 290 is a peptide studied for its potential therapeutic benefits in various inflammatory and autoimmune conditions. Here are some potential benefits associated with ARA 290:

  1. Anti-inflammatory effects: ARA 290 has shown anti-inflammatory properties and, in studies, shows its potential to modulate immune responses and reduce inflammation in certain diseases.
  2. Neuroprotective effects: ARA 290 has demonstrated neuroprotective properties in preclinical studies. It may help protect nerve cells from damage or degeneration and promote neuronal survival.
  3. Pain relief: Studies show ARA 290 can potentially alleviate neuropathic pain, which is pain from damage or dysfunction of the nervous system. It may help reduce pain signals and improve pain management in certain conditions.
  4. Tissue repair and regeneration: ARA 290 can promote tissue repair and regeneration. It can help heal damaged tissues and contribute to overall tissue health.

What is the Mechanism of Action of Ara 290?

ARA 290 exerts its therapeutic effects by modulating the innate repair receptor (IRR), a receptor involved in tissue repair and inflammation regulation. ARA 290 binds to the IRR, activating downstream signaling pathways and promoting anti-inflammatory responses and tissue repair processes.

By binding to the IRR, ARA 290 helps modulate immune responses, reduce inflammation, and promote tissue healing. It can downregulate pro-inflammatory cytokines and upregulate anti-inflammatory cytokines, shifting the balance towards a more favorable anti-inflammatory state.

Additionally, ARA 290 has shown some neuroprotective effects, promoting neuronal survival and reducing pain signals. The exact details of the mechanism of action of ARA 290 are under investigation, and the interaction with the IRR holds promise. It has potential therapeutic results in various inflammatory and autoimmune conditions and neuropathic pain management.

Does ARA-290 Have Side Effects?

ARA-290 is a peptide studied for its therapeutic potential, but information on its side effects is limited. Since it is a relatively new substance, comprehensive data on its safety profile and potential side effects in humans are still being studied. However, in clinical trials and preclinical studies conducted thus far, ARA-290 has generally been well-tolerated, with minimal adverse effects.

It’s important to note that individual medication responses can vary, and some individuals may experience side effects while others may not. Suppose you are considering using ARA-290 or any other medication. In that case, consulting with a healthcare professional who can provide personalized advice based on your medical history and current health condition is crucial.

Furthermore, ARA-290 is under investigation and has no approval for widespread medical use.

ARA-290’s safety and potential side effects still need to be fully understood. Ongoing research and clinical trials are necessary to gather more data and determine the safety profile of ARA-290 in different patient populations.

Summary: ARA-290 For Sale

ARA 290, a research peptide designed to interact specifically with the innate repair receptor that mediates tissue protection. ARA 290 has shown effective as a treatment in clinical studies of metabolic control and neuropathy. Further trials are needed with ARA 290 before it can be used as a treatment, but it is looking hopeful for the future.